MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

Mitochondrial Dysfunction & ER Stress in MS

MStranslate
April 4, 2017
Research, Treatments
Research Summary: Rab32 connects ER stress to mitochondrial defects in multiple sclerosis Mitochondria are often referred to as the ‘powerhouses’ of the cell, as they are largely responsible for the...
Shimmering stars

MS: Many Stories – Shimmering Stars

MStranslate
April 3, 2017
Community, MS: Many Stories
Our latest MS: Many Stories feature is written by Toni, a regular MStranslate contributor and member of our local MS community here in Melbourne, Australia.  If you haven't read Toni's previous...
Ocrevus

US FDA Approves Ocrelizumab (Ocrevus)

MStranslate
March 30, 2017
Ocrelizumab, Treatments
Ocrelizumab (Ocrevus) has been granted US FDA approval for the treatment of both replacing-remitting MS (RRMS) and primary progressive MS (PPMS).  Ocrelizumab is a monoclonal antibody that targets and...

Regulatory T Cells Promote Remyelination

MStranslate
March 26, 2017
Remyelination, Research
Research Summary: Regulatory T cells promote myelin regeneration in the central nervous system When we think about treating multiple sclerosis, generally there are two main approaches that are discussed. ...
pilates

Facebook Live & Real-Time Community Engagement

MStranslate
March 21, 2017
Community, Social Media
In the early part of 2017, MStranslate has begun using Facebook Live broadcasting technology to drive more immediate interaction and engagement with our community.  These events provide Facebook followers an...
MS organisations

The Role of MS Organisations – A Perspective

MStranslate
March 2, 2017
Opinion
An opinion piece by MStranslate co-founder, Brett Drummond “If you're walking down the right path and you're willing to keep walking, eventually you'll make progress” - Barack Obama I am an opinionated...
apitope

Apitope Announce Positive Peptide Therapy Results

MStranslate
February 28, 2017
Research, Treatments
Imagine you have a dog and a cat and they keep fighting. Solution 1: give one of your pets to someone else. Solution 2: Teach them to get along. Solution 1 describes almost all current MS...
muscles

MS: Many Stories – From the MStranslate Community

MStranslate
February 26, 2017
Community, Exercise, Lifestyle, MS: Many Stories
Welcome to part 3 of a series of articles being written by MStranslate community member, Andrew.  You may remember Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
blood test

Can Blood Test Determine Type of Multiple Sclerosis?

MStranslate
February 8, 2017
Basic Sciences, Research
Research Summary: Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression A recent Australian research breakthrough in multiple sclerosis (MS) has drawn...
HALT-MS

HALT-MS: Five Year Study Results

MStranslate
February 2, 2017
Research, Stem Cells, Treatments
Research Summary: High dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS The 5 year results of the HALT-MS trial were today published in Neurology.  The HALT-MS clinical trial has...
  1. 15
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. 21

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.